Adrenomedullin concentrations at two time points following myocardial infarction and prediction of mid-term outcomes

INTRODUCTION: Adrenomedullin (ADM) is a vasopeptide with multiple actions in the cardiovascular system and a potentially powerful tool in comparison to some of the well-established unimodal biomarkers of risk stratification in myocardial infarction (MI). Previous studies on ADM in acute MI were base...

Descripción completa

Detalles Bibliográficos
Autores principales: Dzielińska, Zofia, Małek, Łukasz A., Januszewicz, Andrzej, Prejbisz, Aleksander, Pręgowski, Jerzy, Tyczyński, Paweł, Makowiecka-Cieśla, Magdalena, Janas, Jadwiga, Demkow, Marcin, Ruzyłło, Witold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2011
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264988/
https://www.ncbi.nlm.nih.gov/pubmed/22328879
http://dx.doi.org/10.5114/aoms.2011.26608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264988/
https://www.ncbi.nlm.nih.gov/pubmed/22328879
http://dx.doi.org/10.5114/aoms.2011.26608

Ejemplares similares